Phibro Animal Health Co. (NASDAQ:PAHC) Receives $15.00 Average PT from Brokerages

Phibro Animal Health Co. (NASDAQ:PAHC) has been given an average rating of “Strong Sell” by the five brokerages that are presently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating and two have assigned a hold rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $15.00.

Several analysts have recently issued reports on the stock. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Bank of America increased their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th.

Phibro Animal Health Trading Up 0.3 %

NASDAQ PAHC opened at $23.18 on Wednesday. The stock has a market capitalization of $938.79 million, a price-to-earnings ratio of 386.40, a PEG ratio of 0.58 and a beta of 0.52. The business’s fifty day moving average is $22.17 and its 200-day moving average is $18.99. The company has a debt-to-equity ratio of 1.79, a current ratio of 2.94 and a quick ratio of 1.64. Phibro Animal Health has a one year low of $9.40 and a one year high of $25.11.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Equities research analysts predict that Phibro Animal Health will post 1.57 EPS for the current year.

Insider Buying and Selling

In other news, Director E Thomas Corcoran purchased 5,000 shares of Phibro Animal Health stock in a transaction dated Wednesday, September 4th. The stock was purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the transaction, the director now directly owns 25,000 shares of the company’s stock, valued at approximately $500,500. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 50.07% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Phibro Animal Health

Several large investors have recently added to or reduced their stakes in PAHC. Illinois Municipal Retirement Fund raised its holdings in shares of Phibro Animal Health by 7.2% in the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after acquiring an additional 765 shares in the last quarter. CWM LLC increased its position in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in Phibro Animal Health by 7.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after purchasing an additional 1,063 shares in the last quarter. China Universal Asset Management Co. Ltd. lifted its position in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. Finally, Cardinal Capital Management grew its stake in Phibro Animal Health by 4.7% in the 2nd quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock worth $940,000 after buying an additional 2,520 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.